Constellation Pharmaceuticals, Inc.
COMBINATIONS OF EZH2 INHIBITORS WITH FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER

Last updated:

Abstract:

Provided herein are methods of treating cancer using an effective amount of an EZH2 inhibitor and an effective amount of a second agent. Also provided are compositions comprising an EZH2 inhibitor and an effective amount of a second agent.

Status:
Application
Type:

Utility

Filling date:

27 Jul 2016

Issue date:

26 Mar 2020